PMC2833316_01
Molecular responses during the entire observation period.
AH2010-136252.001.jpg
PMC2833316_01_AH2010-136252.001.jpg
fig1
According to the therapeutic protocols, the dasatinib dose was reduced to 40 mg b.i.d (Figure 1).